Clinical Trial Update: Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating closed-loop automatic control of FiO2 in extremely preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Premature
• Premature Infant Conditions

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Infant,Premature | Phase 3 | Status: ACTIVE_NOT_RECRUITING